We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.2B
AUM Growth
+$2.41B
Cap. Flow
-$59.6M
Cap. Flow %
-0.17%
Top 10 Hldgs %
26.19%
Holding
2,465
New
206
Increased
1,202
Reduced
956
Closed
98

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$31.6M
2
PETS icon
PetMed Express
PETS
+$29.7M
3
ALB icon
Albemarle
ALB
+$27.7M
4
WMT icon
Walmart Inc
WMT
+$27.2M
5
NEE icon
NextEra Energy
NEE
+$27M

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 14.5%
3 Communication Services 10.43%
4 Healthcare 10.27%
5 Financials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
1726
Ollie's Bargain Outlet
OLLI
$4.01B
$382K ﹤0.01%
4,541
-54
-1% -$4.7K
KLRS
1727
Kalaris Therapeutics
KLRS
$88.7M
$382K ﹤0.01%
841
+105
+14% +$54.2K
TELL
1728
DELISTED
Tellurian Inc.
TELL
$382K ﹤0.01%
82,235
+37,316
+83% +$114K
HCM icon
1729
HUTCHMED
HCM
$1.89B
$381K ﹤0.01%
9,693
+2,504
+35% +$72.3K
ALEX
1730
DELISTED
Alexander & Baldwin
ALEX
$380K ﹤0.01%
20,769
-632
-3% -$11.6K
MLAB icon
1731
Mesa Laboratories
MLAB
$539M
$380K ﹤0.01%
1,403
-7
-0.5% -$1.77K
BKD icon
1732
Brookdale Senior Living
BKD
$3.62B
$379K ﹤0.01%
48,017
-1,063
-2% -$7.64K
CXT icon
1733
Crane NXT
CXT
$3.04B
$379K ﹤0.01%
11,824
+248
+2% +$8.1K
NEU icon
1734
NewMarket
NEU
$7.17B
$379K ﹤0.01%
1,177
+248
+27% +$86.7K
TVTX icon
1735
Travere Therapeutics
TVTX
$5.33B
$379K ﹤0.01%
25,987
+3,231
+14% +$63.7K
AIR icon
1736
AAR Corp
AIR
$5.15B
$377K ﹤0.01%
9,727
-241
-2% -$9.7K
GPRO icon
1737
GoPro
GPRO
$116M
$377K ﹤0.01%
32,399
-345
-1% -$3.89K
PLCE icon
1738
Children's Place
PLCE
$53.6M
$377K ﹤0.01%
4,046
-181
-4% -$15.4K
RDUS
1739
DELISTED
Radius Health, Inc.
RDUS
$376K ﹤0.01%
20,632
+1,992
+11% +$39.6K
CALM icon
1740
Cal-Maine
CALM
$4.28B
$372K ﹤0.01%
10,274
-727
-7% -$27.2K
GRFS
1741
Grifois
GRFS
$5.16B
$372K ﹤0.01%
21,455
+4,994
+30% +$89.5K
HRTX icon
1742
Heron Therapeutics
HRTX
$86.3M
$372K ﹤0.01%
23,968
+551
+2% +$8.77K
CLR
1743
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$372K ﹤0.01%
+9,791
New +$304K
TBPH icon
1744
Theravance Biopharma
TBPH
$874M
$371K ﹤0.01%
25,560
+4,193
+20% +$78.7K
AVIR icon
1745
Atea Pharmaceuticals
AVIR
$379M
$370K ﹤0.01%
17,203
+13,097
+319% +$394K
EB
1746
DELISTED
Eventbrite
EB
$370K ﹤0.01%
19,474
+2,285
+13% +$48.5K
PK icon
1747
Park Hotels & Resorts
PK
$2.97B
$370K ﹤0.01%
17,964
-310
-2% -$6.64K
PLRX icon
1748
Pliant Therapeutics
PLRX
$67.5M
$370K ﹤0.01%
12,692
+1,364
+12% +$42.5K
USNA icon
1749
Usana Health Sciences
USNA
$394M
$370K ﹤0.01%
3,609
+167
+5% +$16.8K
AZZ icon
1750
AZZ Inc
AZZ
$4.5B
$369K ﹤0.01%
7,133
-369
-5% -$19.4K

Similar funds

ProShare Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, ProShare Advisors held 2,465 positions worth $34.2B, up 7.6% from $31.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors's Q2 2021 filing shows 206 new, 1,202 increased, 956 reduced and 98 closed positions. Its largest new stake was Trinity Industries: 371,743 shares worth $10M. The largest sale was Amazon, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q2 2021 buy was Trinity Industries: 371,743 shares worth $10M.
  • ProShare Advisors added most to Johnson & Johnson in Q2 2021, an estimated $31.6M increase.
  • ProShare Advisors's biggest Q2 2021 reduction was Amazon, cutting an estimated $155M.
  • ProShare Advisors fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $60.1M.
  • ProShare Advisors's ten largest holdings make up 26% of its $34.2B portfolio in Q2 2021.
  • ProShare Advisors opened 206 new positions and closed 98 in Q2 2021.
  • ProShare Advisors's portfolio value rose 7.6% quarter-over-quarter to $34.2B.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.